¼¼°èÀÇ Ã¼¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå : À¯Çüº°, ÄÄÆ÷³ÍÆ®º°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
External Counterpulsation Devices Market, By Type, By Component, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1555705
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 378 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,503,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,443,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,829,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå ±Ô¸ð´Â 2023³â 8¾ï 5,412¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2032³â±îÁö º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.8%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå : ½ÃÀå ¿ªÇÐ

½ÉÇ÷°ü ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϸé ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ¼ö¿ä°¡ Áõ°¡ÇÕ´Ï´Ù.

½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ¼ö¿ä¸¦ Å©°Ô ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ¹Ì±¹ ½ÉÀåÇùȸ¿¡ µû¸£¸é ½ÉÇ÷°ü°è ÁúȯÀº ¿©ÀüÈ÷ ¼¼°è »ç¸ÁÀÇ 1À§ÀÌ¸ç ¿¬°£ ¾à 1, 800¸¸ ¸íÀÌ »ç¸ÁÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼­´Â ½ÉÀ庴ÀÌ 1, 600¸¸ ¸í ÀÌ»óÀÇ ¼ºÀο¡°Ô ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, ºñħ½ÀÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ Å« ¿ä±¸°¡ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù. ½ÉÀå ±â´ÉÀ» °³¼±Çϰí Çù½ÉÁõÀÇ Áõ»óÀ» ¿ÏÈ­ÇÏ´Â È¿°ú·Î ¾Ë·ÁÁø ü¿Ü ¼øÈ¯ ¿ä¹ýÀº Á¾ÇÕÀûÀÎ ½ÉÇ÷°ü Ä¡·áÀÇ ÀÏȯÀ¸·Î Á¡Á¡ ´õ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. °Ç°­ °ü¸® ½Ã½ºÅÛ°ú ȯÀÚ°¡ ħ½ÀÀû Ä¡·á¾øÀÌ ½ÉÀå »óŸ¦ °ü¸®ÇÏ´Â Çõ½ÅÀûÀÎ ¹æ¹ýÀ» ã´Â µ¿¾È ±â¼úÀÇ Áøº¸¿Í ¿¹¹æÀûÀÎ ½ÉÀåÇ÷°ü °Ç°­¿¡ ´ëÇÑ °ü½ÉÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå : ÁÖ¿ä ÀλçÀÌÆ®·Â

¿ì¸®ÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È¿¡ ¾à 7.8%ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

À¯Çüº° ¼¼ºÐÈ­¿¡¼­´Â EECP ÀåÄ¡°¡ 2023³â¿¡ ÃÖ´ë ½ÃÀå Á¡À¯À²À» º¸¿©ÁÙ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÄÄÆ÷³ÍÆ®º°·Î´Â 2023³â ÄܼÖÀÌ ÁÖ¿ä À¯ÇüÀ̾ú½À´Ï´Ù.

¿ëµµº°·Î´Â Çù½ÉÁõÀÌ 2023³âÀÇ ÁÖ¿ä À¯ÇüÀ̾ú½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¼öÀÍÀ¸·Î À̲ø¾ú½À´Ï´Ù.

ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå : ¼¼ºÐÈ­ ºÐ¼® :

ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀåÀº À¯Çü, ÄÄÆ÷³ÍÆ®, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº À¯Çü¿¡ µû¶ó 2°¡Áö·Î ºÐ·ùµÈ´Ù: °­È­Çü ü¿Ü½Ä Ä«¿îÅÍ ÆÞ¼¼À̼Ç(EECP) ±â±â¿Í ¼øÂ÷Çü ü¿Ü½Ä Ä«¿îÅÍ ÆÞ¼¼À̼Ç(SECP) ±â±âÀÔ´Ï´Ù. °­È­µÈ ü¿Ü½Ä Ä«¿îÅÍ ÆÞ¼¼À̼Ç(EECP) Àåºñ´Â ÷´Ü ±â¼ú°ú ±¤¹üÀ§ÇÑ ÀÓ»ó Àû¿ëÀ¸·Î ¿ì¼± ¼øÀ§°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¼øÂ÷Àû ü¿Ü½Ä Ä«¿îÅÍ ÆÞ¼¼À̼Ç(SECP) ÀåÄ¡°¡ ÀÌ¿¡ À̾î È¿°úÀûÀÎ Ä¡·á¸¦ Á¦°øÇÏÁö¸¸, º¸´Ù Àü¹®ÀûÀÎ ¿ëµµ°¡ ÀÖ½À´Ï´Ù.

½ÃÀåÀº ºÎǰ¿¡ µû¶ó ³× °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. Ä¿ÇÁ, È£½º, ÄܼÖ, ¸ð´ÏÅÍÀÔ´Ï´Ù. ÄܼÖÀº ÀåÄ¡ÀÇ ÀÛµ¿ ¹× Á¦¾î ¿ªÇÒÀ» ¼öÇàÇϱ⠶§¹®¿¡ °¡Àå Áß¿äÇÑ ±¸¼º ¿ä¼ÒÀÔ´Ï´Ù. Ä¿ÇÁ¿Í ¸ð´ÏÅÍ´Â Ä¡·á Á¦°ø°ú ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ÇʼöÀûÀ̸ç È£½ºµµ ÇÊ¿äÇÏÁö¸¸ ¿ì¼± ¼øÀ§´Â ³·½À´Ï´Ù.

ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå : Áö¸®Àû ÀλçÀÌÆ®

ºÏ¹Ì´Â ÷´Ü ÀÇ·á ½Ã¼³, ½ÉÇ÷°ü ÁúȯÀÇ ³ôÀº À¯º´·ü, Çõ½ÅÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ °­ÇÑ °ü½ÉÀ¸·Î ÀÎÇØ ƯÈ÷ ¹Ì±¹¿¡¼­ ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. À̾î À¯·´ÀÌ À̾îÁ® µ¶ÀÏ, ÇÁ¶û½º, ¿µ±¹ µî ÀÇ·áÁ¦µµ°¡ Ãæ½ÇÇÏ°í ºñħ½ÀÀû ½ÉÇ÷°ü°è Ä¡·á¹ýÀÇ µµÀÔÀÌ ÁøÇàµÇ°í ÀÖ´Â ±¹°¡¿¡¼­ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº °Ç°­ °ü¸® ÅõÀÚ Áõ°¡¿Í °í±Þ ½ÉÇ÷°ü Ä¡·á¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡·Î ÀÎÇØ ƯÈ÷ Áß±¹°ú ÀϺ»¿¡¼­ ±Þ¼ÓÇÑ È®´ë¸¦ º¼ ¼ö ÀÖ½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ÀÇ ½ÅÈï ½ÃÀå¿¡¼­µµ °Ç°­ °ü¸® ½Ã½ºÅÛÀÌ ¹ßÀüÇϰí Çõ½ÅÀûÀÎ Ä¡·á¿¡ ´ëÇÑ ¾×¼¼½º°¡ °³¼±µÊ¿¡ µû¶ó µµÀÔÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áö¿ª Â÷ÀÌ´Â ½ÉÇ÷°ü Ä¡·á¿¡ ´ëÇÑ ¿ä±¸ÀÇ È®»ê°ú Áö¿ª¿¡ µû¶ó ´Ù¸¥ °Ç°­ °ü¸® ÀÎÇÁ¶ó¿Í ±â¼ú µµÀÔ ¼öÁØÀ» ¸ðµÎ ¹Ý¿µÇÕ´Ï´Ù.

ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå : °æÀï ±¸µµ:

ü¿Ü½Ä Ä«¿îÅÍ ÆÞ¼¼ÀÌ¼Ç ±â¼úÀÇ ¼±±¸ÀÚÀÎ Vasomedical»ç³ª, ¼±ÁøÀûÀÎ ±â±â ¼³°è·Î ¾Ë·ÁÁø TidePool»ç µîÀÇ ±â¾÷ÀÌ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. Keeley Technologies¿Í CardioFlow´Â ´Ù¾çÇÑ È¯ÀÚÀÇ ¿ä±¸¸¦ ÃæÁ·Çϰí Ä¡·á ¼ºÀûÀ» Çâ»ó½Ã۱â À§ÇØ ±â´ÉÀ» °­È­ÇÑ ´Ù¾çÇÑ Àåºñ¸¦ Á¦°øÇÕ´Ï´Ù. °æÀï ±¸µµÀº ÀåºñÀÇ È¿´É°ú ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½ÃŰ´Â µ¥ ÁßÁ¡À» µÐ ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ» Ư¡À¸·Î ÇÕ´Ï´Ù. °¢ ȸ»ç´Â °í±Þ ¸ð´ÏÅ͸µ ¹× Ä¡·á ±â´ÉÀ» ÅëÇÕÇÑ Â÷¼¼´ë Àåºñ °³¹ßÀ» À§ÇØ ¿¬±¸ °³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿ÍÀÇ Àü·«Àû Á¦ÈÞ ¹× Çù·Â °ü°èµµ ÀϹÝÀûÀÌ¸ç °¢ ȸ»ç ½ÃÀå È®´ë ¹× ¼­ºñ½º Á¦°ø Çâ»ó¿¡ µµ¿òÀÌ µË´Ï´Ù. ½ÃÀå ¿ªÇÐÀº ±â¼ú Çõ½Å°ú ȯÀÚ Á᫐ Á¢±Ù¹ýÀ» ÅëÇØ ½ÉÇ÷°ü Ä¡·á¸¦ °­È­ÇÏ´Â ¾à¼ÓÀ» ¹Ý¿µÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±âÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â »ê¾÷ ¿¬±¸

Á¦5Àå ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå »óȲ

Á¦7Àå ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå :À¯Çüº°

Á¦8Àå ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

Á¦9Àå ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå : ¿ëµµº°

Á¦10Àå ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦11Àå ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ½ÃÀå : Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® - ü¿Ü½Ä Ä«¿îÅÍÆÞ¼¼ÀÌ¼Ç ±â±â ¾÷°è

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

External Counterpulsation Devices Market size was valued at USD 854.12 Million in 2023, expanding at a CAGR of 7.8% from 2024 to 2032.

The External Counterpulsation Devices Market focuses on non-invasive cardiovascular therapies designed to improve heart function and alleviate symptoms of heart disease. These devices use pneumatic cuffs to enhance blood flow and reduce the workload on the heart. The increasing prevalence of cardiovascular diseases, which the World Health Organization estimates contribute to 32% of global deaths, is driving demand for effective non-invasive treatments. Advances in technology and growing awareness about the benefits of external counterpulsation therapy further propel market growth. However, the high cost of devices and the need for specialized medical facilities to operate them present challenges. Opportunities lie in expanding the market through innovation in device design and improving accessibility in emerging markets. The integration of these devices into comprehensive cardiovascular care programs offers the potential for significant impact, addressing both preventive and therapeutic needs in heart disease management.

External Counterpulsation Devices Market- Market Dynamics

Increasing Prevalence of Cardiovascular Diseases Boosts Demand for External Counterpulsation Devices

The rising prevalence of cardiovascular diseases is significantly boosting the demand for External Counterpulsation Devices. According to the American Heart Association, cardiovascular disease remains the leading cause of death globally, accounting for nearly 18 million deaths annually. In the United States, heart disease affects over 16 million adults, creating a substantial need for non-invasive treatment options. External counterpulsation therapy, known for its effectiveness in improving heart function and reducing angina symptoms, is increasingly sought after as part of comprehensive cardiovascular care. As healthcare systems and patients seek innovative ways to manage heart conditions without invasive procedures, the demand for these devices continues to grow, driven by advancements in technology and a heightened focus on preventive cardiovascular health.

External Counterpulsation Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.8% over the forecast period (2024-2032)

Based on Type segmentation, EECP Devices was predicted to show maximum market share in the year 2023

Based on Component segmentation, Consoles was the leading type in 2023

Based on Application segmentation, Angina Pectoris was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

External Counterpulsation Devices Market- Segmentation Analysis:

The Global External Counterpulsation Devices Market is segmented based on Type, Component, Application, End-User, and Region.

The market is divided into two categories based on Type: Enhanced External Counterpulsation (EECP) Devices and Sequential External Counterpulsation (SECP) Devices. Enhanced External Counterpulsation (EECP) Devices hold higher priority due to their advanced technology and broader clinical applications. Sequential External Counterpulsation (SECP) Devices follow, offering effective therapy but with more specialized uses.

The market is divided into four categories based on Components: Cuffs, Hoses, Consoles, and Monitors. Consoles are the most crucial component due to their role in device operation and control. Cuffs and Monitors follow, essential for therapy delivery and patient monitoring, while Hoses are also necessary but less prioritized.

External Counterpulsation Devices Market- Geographical Insights

North America leads the market, particularly in the United States, due to its advanced healthcare facilities, high prevalence of cardiovascular diseases, and strong focus on innovative treatment options. Europe follows, with significant growth in countries like Germany, France, and the UK, where there is a robust healthcare system and increasing adoption of non-invasive cardiovascular therapies. The Asia-Pacific region is experiencing rapid expansion, particularly in China and Japan, due to rising healthcare investments and growing awareness of advanced cardiovascular treatments. Emerging markets in Latin America and the Middle East are also seeing increased adoption as healthcare systems evolve and access to innovative treatments improves. This geographical variation reflects both the widespread need for cardiovascular care and the differing levels of healthcare infrastructure and technology adoption across regions.

External Counterpulsation Devices Market- Competitive Landscape:

Companies such as Vasomedical, a pioneer in external counterpulsation technology, and TidePool, known for its advanced device designs, dominate the market. Keeley Technologies and CardioFlow, offer a range of devices with enhanced features, aiming to meet diverse patient needs and improve therapeutic outcomes. The competitive landscape is characterized by ongoing advancements in technology, with a focus on improving device efficacy and patient comfort. Companies are investing in R&D to develop next-generation devices that integrate advanced monitoring and therapeutic capabilities. Additionally, strategic partnerships and collaborations with healthcare providers are common, helping companies expand their market reach and improve their service offerings. The market dynamics reflect a commitment to enhancing cardiovascular care through innovation and a patient-centered approach.

Recent Developments:

In June 2022, Heal Your Heart opened its new enhanced external counterpulsation center in Neelankarai, India. The facility, featuring nine rooms dedicated to EECP treatment, is now the largest of its kind in the country.

In February 2020, Enso S&A Health House Sdn. Bhd. (Enso) and My Life Centre (MLC) expanded their services by opening two new external counterpulsation (ECP) centers in Johor Bahru and Kota Bahru, Malaysia, focusing on alternative medicine and therapy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL EXTERNAL COUNTERPULSATION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL EXTERNAL COUNTERPULSATION DEVICES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL EXTERNAL COUNTERPULSATION DEVICES MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

GLOBAL EXTERNAL COUNTERPULSATION DEVICES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL EXTERNAL COUNTERPULSATION DEVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL EXTERNAL COUNTERPULSATION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. External Counterpulsation Devices Market Overview

2. Executive Summary

3. External Counterpulsation Devices Key Market Trends

4. External Counterpulsation Devices Industry Study

5. External Counterpulsation Devices Market: COVID-19 Impact Analysis

6. External Counterpulsation Devices Market Landscape

7. External Counterpulsation Devices Market - By Type

8. External Counterpulsation Devices Market - By Component

9. External Counterpulsation Devices Market - By Application

10. External Counterpulsation Devices Market - By End-User

11. External Counterpulsation Devices Market- By Geography

12. Key Vendor Analysis- External Counterpulsation Devices Industry

13. 360 Degree Analyst View

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â